معرفی
Dr. John Zimmerman is an incoming faculty member at the Meinig School of Biomedical Engineering at Cornell University, starting in summer 2025. His research lies at the interface of living and non-living systems, focusing on understanding the fundamental structure-function relationships in the human body through computational and tissue-engineered models.
Education:
- B.A. in Chemistry, Whitman College (2011)
- Ph.D. in Chemistry, University of Chicago (2016)
- Postdoctoral Training in Cardiac Tissue Engineering, Harvard University (2025)
Dr. Zimmerman’s research interests include biomechanics, mechanobiology, tissue engineering, biomaterials, drug delivery, nanomedicine, and molecular and cellular engineering. He applies these to critical areas such as cardiac development, heart function, cardiomyopathies, and nanoparticle-cell interactions. His work integrates computational modeling, machine learning, and experimental tissue engineering to recreate emergent tissue-scale phenomena.
His recent publications reveal a strong trend in biohybrid systems, engineered heart tissues, disease modeling using iPSCs, and nanomaterial-tissue interactions. He frequently employs advanced fabrication techniques like rotary jet spinning and 3D bioprinting, combined with machine learning, to optimize biological designs and understand structure-function relationships.
Scientific Awards and Honors:
- NIH NRSA T32 Fellowship: Boston Children’s Hospital Cardiology Training Program (2022–2023)
- NIH NRSA T32 Fellowship: Organ Design and Engineering Training (ODET) Program (2017–2019)
- Biomedical Consortium Scholar (2014–2016)
Dr. Zimmerman has been involved in significant research grants and training programs, particularly through NIH-funded fellowships. While his formal advising history is not listed, his role as a new faculty member at Cornell implies future mentorship of graduate students and postdoctoral researchers. His research is highly collaborative, often involving teams at Harvard and Boston Children’s Hospital, particularly within the Disease Biophysics Group led by Kevin Kit Parker.
His work has centered on developing innovative tissue-engineered models of the heart, including biohybrid swimmers, ventricular models, and disease-specific platforms for arrhythmogenic cardiomyopathy and Duchenne muscular dystrophy. These models integrate mechanical, electrical, and fluid-dynamic simulations with experimental validation, forming a robust platform for future work in regenerative medicine and personalized disease modeling.
حوزههای پژوهشی
